Pace Lubin


Click here to see Photos and Video and Highlights

Business Strategy


Fredric Price, Chairman & CEO, Chiasma
Fredric D. Price is Chairman and CEO of Chiasma and a member of the Board of Directors of Enobia Pharma. Previously, he was Chairman of Omrix Biopharmaceuticals, a member of the Board of Directors of Pharmasset, Executive Chairman of Peptimmune, Chairman & CEO of BioMarin Pharmaceutical and CEO and a member of the Board of Directors of Applied Microbiology. As Chairman and/or CEO, he has raised more than $500 million in a variety of securities transactions, led a total of 18 M&A and licensing transactions, built FDA approved facilities and had drugs approved in the US as well as in international markets. His earlier experience includes having been Vice President of Finance and Administration and CFO of Regeneron Pharmaceuticals, the founder of the strategy consulting firm RxFDP, and Vice President of Pfizer Pharmaceuticals with both line and staff responsibilities. Mr. Price is a co-inventor of 13 issued US patents. He received a BA from Dartmouth College and an MBA from the Wharton School of the University of Pennsylvania.
  [Fredric Price]